Avantika Daing

As Founding Partner of Plum Alley Ventures Company and General Partner of Fund I, Avantika spearheads strategy and the Fund and Syndicate Investments. She leads the firm's Investment strategy with a focus on investing in innovation in frontier technologies - across deep tech and medical breakthrough companies with gender diverse founding teams. Having deployed over $100 Million, across 32+ companies, the platfrom offer institutions, LPs and direct investors the opportunity to invest in early to late stage private companies that are transforming the world. The Portfolio boasts of 2 Unicorns and 2 exits, and includes MAMMOTH BIOSCIENCES, EINRIDE, AIR PROTEIN, AIFI, ACLIMA, DILIGENT ROBOTICS, BIOBOT ANALYTICS, ONE CONCERN, KETOS, EPIBONE, VyV, ASHVATTHA THERAPEUTICS among others.